Form 8-K - Current report:
SEC Accession No. 0001698530-21-000107
Filing Date
2021-12-10
Accepted
2021-12-10 17:25:56
Documents
17
Period of Report
2021-12-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xcur-20211210.htm   iXBRL 8-K 63683
2 EX-10.1 exhibit101_midcapamendment.htm EX-10.1 78699
3 EX-10.2 exhibit102_bock.htm EX-10.2 37089
4 EX-10.3 exhibit103_schroff.htm EX-10.3 27417
5 EX-99.1 ex991_pressreleasex121021.htm EX-99.1 24657
9 image_0a.jpg GRAPHIC 10969
  Complete submission text file 0001698530-21-000107.txt   427525

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20211210.xsd EX-101.SCH 1905
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20211210_lab.xml EX-101.LAB 24831
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20211210_pre.xml EX-101.PRE 13045
10 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20211210_htm.xml XML 10984
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39011 | Film No.: 211486373
SIC: 2834 Pharmaceutical Preparations